Unexpected structure for the N-terminal domain of hepatitis C virus envelope glycoprotein E1

Nature Communications

Volumn 5, Issue , 2014, Pages

  El Omari, Kamel ^a   Iourin, Oleg ^a   Kadlec, Jan ^a   Sutton, Geoff ^a   Harlos, Karl ^a   Grimes, Jonathan M ^a,b,c   Stuart, David I ^a,b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b DIAMOND LIGHT SOURCE LTD   (United Kingdom)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E1; HOMODIMER; HYBRID PROTEIN; MONOMER; N ACETYLGLUCOSAMINE; E1 PROTEIN, HEPATITIS C VIRUS; RECOMBINANT PROTEIN; VIRUS ENVELOPE PROTEIN;

CRYSTAL STRUCTURE; HEPATITIS; HOST; INFECTIOUS DISEASE; MEMBRANE; PROTEIN; VIRUS;

AMINO TERMINAL SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DISULFIDE BOND; HEPATITIS C; HEPATITIS C VIRUS; HINGE REGION; HOST CELL; HYDROGEN BOND; HYDROPHOBICITY; LIGHT SCATTERING; MEMBRANE FUSION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PURIFICATION; PUBLIC HEALTH PROBLEM; SURFACE PROPERTY; AMINO ACID SEQUENCE; CHEMISTRY; GENE EXPRESSION; GENETICS; HEK293 CELL LINE; HEPACIVIRUS; HUMAN; MOLECULAR GENETICS; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; X RAY CRYSTALLOGRAPHY;

HEPATITIS C VIRUS;

AMINO ACID SEQUENCE; CRYSTALLOGRAPHY, X-RAY; GENE EXPRESSION; HEK293 CELLS; HEPACIVIRUS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; VIRAL ENVELOPE PROTEINS;

EID: 84923348810     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5874     Document Type: Article

References (32)

1. Lavanchy, D. Chronic viral hepatitis as a public health issue in the world. Best Pract. Res. Clin. Gastroenterol. 22, 991-1008 (2008).
2. Hatzakis, A. et al. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference∗. J. Viral. Hepat. 18(Suppl 1): 1-16 (2011).
3. Pawlotsky, J. M. New Hepatitis C Virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development. Semin. Liver Dis. 34, 22-29 (2014).
4. Lavie, M., Goffard, A. & Dubuisson, J. in Hepatitis C Viruses: Genomes and Molecular Biology (ed. Tan, S. L.) (Norfolk, 2006).
5. Vieyres, G. et al. Characterization of the envelope glycoproteins associated with infectious hepatitis C virus. J. Virol. 84, 10159-10168 (2010).
6. Samreen, B. et al. Hepatitis C virus entry: role of host and viral factors. Infect. Genet. Evol. 12, 1699-1709 (2012).
7. Mazumdar, B., Banerjee, A., Meyer, K. & Ray, R. Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes. Hepatology 54, 1149-1156 (2011).
8. El Omari, K., Iourin, O., Harlos, K., Grimes, J. M. & Stuart, D. I. Structure of a pestivirus envelope glycoprotein E2 clarifies its role in cell entry. Cell Rep. 3, 30-35 (2013).
9. Kong, L. et al. Hepatitis C virus E2 envelope glycoprotein core structure. Science 342, 1090-1094 (2013).
10. Khan, A. G. et al. Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2. Nature 509, 381-384 (2014).
11. Kielian, II M. Class virus membrane fusion proteins. Virology 344, 38-47 (2006).
12. El Omari, K. et al. Pushing the limits of sulfur SAD phasing: de novo structure solution of the N-terminal domain of the ectodomain of HCV E1. Acta Crystallogr. D Biol. Crystallogr. 70, 2197-2203 (2014).
13. Emekli, U., Schneidman-Duhovny, D., Wolfson, H. J., Nussinov, R. & Haliloglu, T. HingeProt: automated prediction of hinges in protein structures. Proteins 70, 1219-1227 (2008).
14. Lawrence, M. C. & Colman, P. M. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234, 946-950 (1993).
15. Wahid, A. et al. Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein. J. Virol. 87, 1605-1617 (2013).
16. Fraser, J., Boo, I., Poumbourios, P. & Drummer, H. E. Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry. J. Biol. Chem. 286, 31984-31992 (2011).
17. Garry, R. F. & Dash, S. Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins. Virology 307, 255-265 (2003).
18. Holm, L. & Rosenstrom, P. Dali server: conservation mapping in 3D. Nucleic Acids Res. 38, W545-W549 (2010).
19. Drummer, H. E., Boo, I. & Poumbourios, P. Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1. J. Gen. Virol. 88, 1144-1148 (2007).
20. Li, H. F., Huang, C. H., Ai, L. S., Chuang, C. K. & Chen, S. S. Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entry. J. Biomed. Sci. 16, 89 (2009).
21. Perez-Berna, A. J., Moreno, M. R., Guillen, J., Bernabeu, A. & Villalain, J. The membrane-active regions of the hepatitis C virus E1 and E2 envelope glycoproteins. Biochemistry 45, 3755-3768 (2006).
22. Jiang, J. et al. Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate. J. Virol. 86, 7256-7267 (2012).
23. Aricescu, A. R., Lu, W. & Jones, E. Y. A time-and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr. D Biol. Crystallogr. 62, 1243-1250 (2006).
24. Walter, T. S. et al. A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallogr. D Biol. Crystallogr. 61, 651-657 (2005).
25. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1996).
26. Winter, G., Lobley, C. M. & Prince, S. M. Decision making in xia2. Acta Crystallogr. D Biol. Crystallogr. 69, 1260-1273 (2013).
27. Sheldrick, G. M. Experimental phasing with SHELXC/D/E: combining chain tracing with density modification. Acta Crystallogr. D Biol. Crystallogr. 66, 479-485 (2010).
28. Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58, 1948-1954 (2002).
29. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004).
30. Bricogne, G. et al. Cambridge: BUSTER-TNT 2.5.1 and autoBUSTER 1.3.1 (Global Phasing Ltd, 2008).
31. Davis, I. W. et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35, W375-W383 (2007).
32. Gouet, P., Robert, X. & Courcelle, E. ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins. Nucleic Acids Res. 31, 3320-3323 (2003).